TABLE 2:

Mean susceptibility (χ), mean R₂^*, and corrected volume of ROI in controls and all HD patients.

	χ (ppm)		R2*(s−1)		Corrected Volume (mL)
	Control	All HD	Control	All HD	Control	All HD
CN	0.041 ± 0.004	0.056 ± 0.004*	45.26 ± 1.51	50.86 ± 2.47*	8.0 ± 0.2	6.5 ± 0.3***
PT	0.061 ± 0.006	0.084 ± 0.007***	54.41 ± 2.51	59.51 ± 2.32*	9.0 ± 0.2	7.3 ± 0.5**
GP	0.132 ± 0.004	0.155 ± 0.008*	82.86 ± 3.30	88.76 ± 3.73	4.3 ± 0.2	3.5 ± 0.2**
HIPP	−0.005 ± 0.002	−0.003 ± 0.002	31.94 ± 1.20	29.51 ± 1.14	6.8 ± 0.2	6.8 ± 0.1
SN	0.113 ± 0.008	0.115 ± 0.008	81.97 ± 5.32	84.32 ± 3.05	1.5 ± 0.1	1.3 ± 0.1**
RN	0.081 ± 0.011	0.083 ± 0.006	62.82 ± 4.02	69.47 ± 3.80	0.6 ± 0.1	0.6 ± 0.1

NOTES: CN = caudate nuclei, PT = putamen, GP = globus pallidus, HIPP = hippocampus, SN = substantia nigra, RN = red nucleus; Data are presented as means ± standard error (SE)

^*p < 0.05

^**p < 0. 01

^***Significant difference as compared to controls with p < 0.001.